Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

KIT positive

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

KIT mutation (32)

KIT exon 11 mutation (13)

KIT exon 9 mutation (9)

KIT exon 13 mutation (6)

KIT exon 17 mutation (6)

KIT wild-type (3)

KIT W557_V559delinsF (2)

KIT exon 11 mutation + KIT exon 17 mutation (2)

KIT exon 18 mutation (2)

KIT exon 8 mutation (2)

BRAF G466V + KIT K509Q (1)

KDR Q472H + KIT M541L (1)

KIT M552_V555delMYEV (1)

KIT V559A + KIT N822I (1)

KIT V559_E561del (1)

KIT W557_V559>C (1)

KIT W557_V559>F (1)

KIT exon 11 W557_K558delins (1)

KIT exon 14 mutation (1)

KIT exon 17 mutation + KIT exon 18 mutation (1)

KIT translocation (1)

NR4A3 rearrangement + KIT mutation (1)

KIT rs3733542 (0)

KIT mutation (32)

KIT exon 11 mutation (13)

KIT exon 9 mutation (9)

KIT exon 13 mutation (6)

KIT exon 17 mutation (6)

KIT wild-type (3)

KIT W557_V559delinsF (2)

KIT exon 11 mutation + KIT exon 17 mutation (2)

KIT exon 18 mutation (2)

KIT exon 8 mutation (2)

BRAF G466V + KIT K509Q (1)

KDR Q472H + KIT M541L (1)

KIT M552_V555delMYEV (1)

KIT V559A + KIT N822I (1)

KIT V559_E561del (1)

KIT W557_V559>C (1)

KIT W557_V559>F (1)

KIT exon 11 W557_K558delins (1)

KIT exon 14 mutation (1)

KIT exon 17 mutation + KIT exon 18 mutation (1)

KIT translocation (1)

NR4A3 rearrangement + KIT mutation (1)

KIT rs3733542 (0)

›

KIT positive	Gastrointestinal Stromal Tumor	KIT positive	Gastrointestinal Stromal Tumor	imatinib Sensitive: A1 - Approval imatinib Sensitive : A1	imatinib Sensitive: A1 - Approval imatinib Sensitive : A1
KIT positive	Myelodysplastic Syndrome	KIT positive	Myelodysplastic Syndrome	MGTA-117 Sensitive: C3 – Early Trials MGTA-117 Sensitive : C3	MGTA-117 Sensitive: C3 – Early Trials MGTA-117 Sensitive : C3
KIT positive	Acute Myelogenous Leukemia	KIT positive	Acute Myelogenous Leukemia	MGTA-117 Sensitive: C3 – Early Trials MGTA-117 Sensitive : C3	MGTA-117 Sensitive: C3 – Early Trials MGTA-117 Sensitive : C3
KIT positive	Small Cell Lung Cancer	KIT positive	Small Cell Lung Cancer	NN3201 Sensitive: D – Preclinical NN3201 Sensitive : D	NN3201 Sensitive: D – Preclinical NN3201 Sensitive : D
KIT positive	Acute Myelogenous Leukemia	KIT positive	Acute Myelogenous Leukemia	NN3201 Sensitive: D – Preclinical NN3201 Sensitive : D	NN3201 Sensitive: D – Preclinical NN3201 Sensitive : D
KIT positive	Gastrointestinal Stromal Tumor	KIT positive	Gastrointestinal Stromal Tumor	LOP628 Sensitive: D – Preclinical LOP628 Sensitive : D	LOP628 Sensitive: D – Preclinical LOP628 Sensitive : D
KIT positive	Acute Myelogenous Leukemia	KIT positive	Acute Myelogenous Leukemia	LOP628 Sensitive: D – Preclinical LOP628 Sensitive : D	LOP628 Sensitive: D – Preclinical LOP628 Sensitive : D
KIT positive	Small Cell Lung Cancer	KIT positive	Small Cell Lung Cancer	LOP628 Sensitive: D – Preclinical LOP628 Sensitive : D	LOP628 Sensitive: D – Preclinical LOP628 Sensitive : D